{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:19:24Z","timestamp":1760833164205,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"am","delay-in-days":711,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18am0101114"],"award-info":[{"award-number":["JP18am0101114"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bmcl.2024.129649","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T01:01:16Z","timestamp":1707440476000},"page":"129649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lipid bilayer membrane permeability mechanism of the K-Ras(G12D)-inhibitory bicyclic peptide KS-58 elucidated by molecular dynamics simulations"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1295-1623","authenticated-orcid":false,"given":"Kotaro","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatsugu","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129649_b0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbrc.2016.11.035","article-title":"Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis","volume":"482","author":"Sakamoto","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2024.129649_b0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbrc.2016.11.060","article-title":"Discovery of high-affinity BCL6-binding peptide and its structure\u2013activity relationship","volume":"482","author":"Sakamoto","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2024.129649_b0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbrc.2016.12.170","article-title":"Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration","volume":"483","author":"Sakamoto","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2024.129649_b0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbrc.2017.01.147","article-title":"K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology","volume":"484","author":"Sakamoto","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2024.129649_b0025","first-page":"33","article-title":"Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology","volume":"11","author":"Sakamoto","year":"2017","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.bmcl.2024.129649_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.751587","article-title":"Generation of KS-133 as a novel bicyclic peptide with a potent and selective VIPR2 antagonist activity that counteracts cognitive decline in a mouse model of psychiatric disorders","volume":"12","author":"Sakamoto","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2024.129649_b0035","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bmcl.2017.01.023","article-title":"Discovery of peptidic miR-21 processing inhibitor by mirror image phage display: A a novel method to generate RNA binding D-peptides","volume":"27","author":"Sakamoto","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129649_b0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2016.10.009","article-title":"Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c\/betaKlotho complex from random peptide T7 phage display","volume":"480","author":"Sakamoto","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2024.129649_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2016.12.186","article-title":"Generation of a novel artificial TrkB agonist, BM17d99, using T7 phage-displayed random peptide libraries","volume":"483","author":"Ohnishi","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2024.129649_b0050","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acs.jmedchem.7b00237","article-title":"How big is too big for cell permeability?","volume":"60","author":"Matsson","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129649_b0055","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/acs.jmedchem.6b01483","article-title":"Nonclassical size dependence of permeation defines bounds for passive adsorption of large drug molecules","volume":"60","author":"Pye","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129649_b0060","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejmech.2015.01.014","article-title":"Peptide therapeutics: Targeting targeting the undruggable space","volume":"94","author":"Tsomaia","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129649_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2016.03.013","article-title":"Cell permeability beyond the rule of 5","volume":"101","author":"Matsson","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2024.129649_b0070","doi-asserted-by":"crossref","first-page":"E3445","DOI":"10.1073\/pnas.1303002110","article-title":"Stapled \u03b1-helical peptide drug development: A a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy","volume":"110","author":"Chang","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2024.129649_b0075","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/onc.2016.361","article-title":"Mechanistic validation of a clinical lead stapled peptide that reactivates p53 by dual HDM2 and HDMX targeting","volume":"36","author":"Wachter","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bmcl.2024.129649_b0080","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.3390\/molecules24122292","article-title":"Incorporation of putative helix-breaking amino acids in the design of novel stapled peptides: Exploring exploring biophysical and cellular permeability properties","volume":"24","author":"Partridge","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129649_b0085","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/chem.201905385","article-title":"Cyclic peptides as drugs for intracellular targets: The next frontier in peptide therapeutic development","volume":"27","author":"Buckton","year":"2021","journal-title":"Chemistry"},{"key":"10.1016\/j.bmcl.2024.129649_b0090","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.4155\/fmc.15.78","article-title":"Beyond cyclosporine A: Conformation-dependent passive membrane permeabilities of cyclic peptide natural products","volume":"7","author":"Ahlbach","year":"2015","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2024.129649_b0095","doi-asserted-by":"crossref","first-page":"21671","DOI":"10.1038\/s41598-020-78712-5","article-title":"Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo","volume":"10","author":"Sakamoto","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2024.129649_b0100","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1038\/s41598-022-12401-3","article-title":"The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors","volume":"12","author":"Sakamoto","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2024.129649_b0105","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1021\/acs.jcim.6b00251","article-title":"Kinetic models of cyclosporin A in polar and apolar environments reveal multiple congruent conformational states","volume":"56","author":"Witek","year":"2016","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2024.129649_b0110","first-page":"2261","article-title":"Conformational flexibility is a determinant of permeability for cyclosporin","volume":"22","author":"Conan","year":"2018","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.bmcl.2024.129649_b0115","first-page":"1672","article-title":"Molecular simulation of nonfacilitated membrane permeation","volume":"7","author":"Ernest","year":"2016","journal-title":"BBA"},{"key":"10.1016\/j.bmcl.2024.129649_b0120","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.bbamem.2016.03.032","article-title":"Permeability across lipid membranes","volume":"1858(","author":"Shinoda","year":"2016","journal-title":"BBA"},{"key":"10.1016\/j.bmcl.2024.129649_b0125","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.analchem.0c03901","article-title":"Quantitation of cell membrane permeability of cyclic peptides by single-cell cytoplasm mass spectrometry","volume":"93","author":"Kawai","year":"2021","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmcl.2024.129649_b0130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4155\/fmc-2018-0429","article-title":"Toward the elucidation of the mechanism for passive membrane permeability of cyclic peptides","volume":"11","author":"Riniker","year":"2019","journal-title":"Future Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:49:54Z","timestamp":1760773794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":26,"alternative-id":["S0960894X24000519"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129649","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid bilayer membrane permeability mechanism of the K-Ras(G12D)-inhibitory bicyclic peptide KS-58 elucidated by molecular dynamics simulations","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129649"}}